INVESTIGATION OF THE ACTION OF HISTONE DEACETYLASE INHIBITORS IN EX VIVO AND IN VITRO MODELS OF INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Edwards, A. J. P. [1 ]
Gwiggner, M. [1 ]
Claridge, A. G. [1 ]
Morgan-Walsh, R. J. [1 ]
Hayden, A. L. [2 ]
Bateman, A. [3 ]
Cummings, J. R. F. [4 ]
Packham, G. K. [2 ]
Pender, S. L. F. [1 ]
机构：
[1] Univ Southampton, Fac Med, Dept Clin & Expt Sci, Southampton SO9 5NH, Hants, England
[2] Univ Southampton, Dept Canc Sci, Southampton, Hants, England
[3] Univ Hosp Southampton NHS Fdn Trust, Dept Pathol, Southampton, Hants, England
[4] Univ Hosp Southampton NHS Fdn, Dept Gastroenterol, Southampton, Hants, England
来源：
GUT | 2012年 / 61卷
关键词：
D O I：
10.1136/gutjnl-2012-302514a.161
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A69 / A69
页数：1
相关论文
共 50 条
  • [1] The Role of Histone Deacetylase Inhibition in Ex Vivo and In Vitro Models of Inflammatory Bowel Diseases
    Edwards, Alexander J.
    Gwiggner, Markus
    Claridge, Andrew
    Morgan-Walsh, Rebecca
    Hayden, Annette L.
    Bateman, Adrian C.
    Cummings, J. R. Fraser
    Packham, Graham
    Pender, Sylvia L.
    GASTROENTEROLOGY, 2012, 142 (05) : S360 - S360
  • [2] In vitro models and ex vivo systems used in inflammatory bowel disease
    Joshi, Abhishek
    Soni, Arun
    Acharya, Sanjeev
    IN VITRO MODELS, 2022, 1 (03): : 213 - 227
  • [3] Histone Deacetylase Inhibitors In Inflammatory Disease
    Halili, Maria A.
    Andrews, Melanie R.
    Sweet, Matthew J.
    Fairlie, David P.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 309 - 319
  • [4] Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo
    Faraco, Giuseppe
    Pittelli, Maria
    Cavone, Leonardo
    Fossati, Silvia
    Porcu, Marco
    Mascagni, Paolo
    Fossati, Gianluca
    Moroni, Flavio
    Chiarugi, Alberto
    NEUROBIOLOGY OF DISEASE, 2009, 36 (02) : 269 - 279
  • [5] Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases
    Edwards, Alexander J. P.
    Pender, Sylvia L. F.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1092 - 1095
  • [6] Histone deacetylase in inflammatory bowel disease: novel insights
    Li, Chunxiao
    Gu, Shaobo
    Zhang, Yihong
    Zhang, Zhenruo
    Wang, Junzhuo
    Gao, Ting
    Zhong, Kangpeng
    Shan, Keshu
    Ye, Guoliang
    Ke, Yini
    Chen, Yi
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2025, 18
  • [7] Histone deacetylase inhibitors:: Assays to assess effectiveness In vitro and In vivo
    Richon, VM
    Zhou, XB
    Secrist, JP
    Cordon-Cardo, C
    Kelly, WK
    Drobnjak, M
    Marks, PA
    CHROMATIN AND CHROMATIN REMODELING ENZYMES, PT B, 2004, 376 : 199 - +
  • [8] Histone deacetylase inhibitors: evaluation of biological correlates as predictive markers in in vivo and in vitro models.
    Daud, Adil I.
    Marchion, Douglas C.
    Bicaku, Elona
    Schmitt, Morgan
    Munster, Pamela N.
    CANCER RESEARCH, 2006, 66 (08)
  • [9] In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
    Hahnen, E
    Eyüpoglu, IY
    Brichta, L
    Haastert, K
    Tränkle, C
    Siebzehnrübl, FA
    Riessland, M
    Hölker, I
    Claus, P
    Romstöck, J
    Buslei, R
    Wirth, B
    Blümcke, I
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 (01) : 193 - 202
  • [10] Antitumoral Efficacy of Four Histone Deacetylase Inhibitors in Hepatoma In Vitro and In Vivo
    Ganslmayer, Marion
    Konturek, Peter
    Herold, Christoph
    Neurath, Markus F.
    Zopf, Steffen
    ANTICANCER RESEARCH, 2012, 32 (12) : 5263 - 5269
12345